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We report he molecular clo.in~ of human gone ($31) containing an open reading frame of 1095 nucleotides, which encodes a protein of 365 amino 
acids. The encoded protein contains seven hydrophobic putative transmembrane domains considered the hallmark of G protein-coupled receptors. 
The amino acid sequence shows highest homology to receptors for serotonin (5.hydroxytryptamin¢). Expression of this receptor in marine Lt/c- 
cells confen'ed upon these cells the ability to respond to serotonin by inhibition of adenylyl eyclas¢. No response was observed to isoproterenol, 
epinephri,le, histamine, dopamin¢ or melatonin the transfected cells. We propose that the human gone $31 encodes a novel serotonin receptor. 
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1, INTRODUCTION 
Serotonin (5-hydroxytryptamine, 5-HT) mediates a
wide variety of effects, both in the central nervous ys- 
tem and in the periphery, through several different re- 
ceptors, of which at least eight discrete subtypes have 
been proposed based on pharmacological criteria [1]. It 
is not yet known whether all these pharmacologically 
distinguishable r ceptor subtypes are the products ef=s 
many different genes+ or whether some of the pharma- 
cological differences may arise from tissue-specific 
factors such as posttranslational modification or as- 
sociation with one or more distinct G proteins. Molecu- 
lar cloning techniques are now being employed to re- 
solve these questions, and have to date resulted in the 
cloning of five distinct G protein-coupled mammalian 
serotonin receptors: 5-HT~A ('G-21') [2,3], 5-HTtc [4], 
5-HTz [5,6], and two genetically distinct subtypes of the 
5-HTjv receptor [7,8]. The human 5-HTjD receptor se- 
quence reported by Hamblin and Metcalf [7] may re- 
present he human homologue of the canine serotonin 
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receptor-like sequence RDC4 reported by Libert et al. 
[9]. The cloning of a human 5-HTtn-like receptor has 
also been announced by Zgombick et al. [10], but no 
structural information has been given. Additionally, a 
structurally related serotonin receptor has been cloned 
from Drosophila [11]. 
Employing a low-stringency screening approach, we 
now report the molecular cloning of  another genetically 
distinct human serotonin receptor, which we refer to as 
$31. When expressed in murine Ltk- cells, this serotonin 
receptor is shown to mediate inhibition of adenylyl 
cyclase. 
2. MATERIALS AND METHODS 
2.1. Oligonucleotides 
Oligollacleotides u ed as ~¢recning probes and sequencing primers, 
up to 69 naclcotides Cat) long, were synthesized on an Applied Bio- 
systems Model 391 DNA Synthesizer using automated cyaaocthyl- 
phosphoramidite chemistry and prepared for use as described [8]. 
Oligonucleotide probe A was nt 343--411 of the sense strand of the 
human 5-HT~A receptor [2]; probe B was nt 400--468 of the sense strand 
of the rat 5-HTLc receptor [4]. 
2.2. Screening, initial analys~s, subclaning, and sequencing 
An amplified haman lambdaEMBL3 genomic library Ca gift from 
Dr. David Nelson, Department of Molecular Genetic, Baylor College 
of Medicine) was screened at low stringency with oligonucleofide 
probes A and B, as follows. Replicate filters with amplified recom- 
binant phage DNA were prehybridized for 3 h at 42'C in a solution 
containing 5 x Denhardt's solution, 6 × $SC, 0.5% SDS, 100/~8/ml 
sheared salmon sperm DNA and 0.3 M No-phosphate buffer pH 7.0. 
H2,,brid:.zation was tarried out for Ifi h at ,,20C in the same solution 
plus 0.5 × 10 ~ cpm/ml each of probe A and probe B labeled at their 
5' end with -~-'P [12]. The filters were then rin~! three tim~ with 2 x 
SSC/0.I% SDS at room temperature, then washed for 30 min at 6O*C 
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in 2 x SSC/0.5% SDS, and finally for 30 mix at 60°C in 2 × SSC/0.1% 
SDS. The filters were dried and exposed to Kodak X-Omat AR films 
with two intensifying screens at -70°C for 5 days (primary screening) 
or shorter. The high-stringency screening with DNA fragments la- 
beled b), nick translation (0.2 × 10 ~ epm/ml) [12] differed in that after 
the initial rinsings at room temperature, the filters were subjected to 
30 mln washes at 68°C, first with 0,2 x SSC/0.5% SDS and then with 
0.2 x SSC/0.1% SDS. DNA was prepared from plaque-purified hy- 
bridization-positive phages as descril~d [8], and the general strategies 
followed for the isolation of DNA fragments with partial and full 
length ORF's and their DNA sequence determination is outlined in 
Fi~. IA, Briefly, DNA from plaque purified recombinant phages was 
digested with several restriction enzymes, the digests were elec- 
trophore~ed in 0.7% agarose and fragments hat hybridized t.o probes 
A or B were identified by Southern blotting [13]. These fragments were 
then isolated in preparative scale, purified aging Geneelean (BId 101), 
and subcloned into plasmid Bluescript KS(+) (Stratagene). After am- 
plification, both strands of the subeloned DNA inserts were directly 
sequenced by the dideoxy chain termination method of  Sanger et al, 
[14 l, using alkali-denatured plasmid DNA as template. 
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Fig. 1. (A) Summary of molecular cloning and sequencing strategies 
used to characterize the open reading frame of the human $31 gone, 
(B) Scheme of the pKNH expression vector after insertion of $31 
ORF. ORF's are represented asopen boxes, flanking sequences are 
represented as blank lines connected to ORF's; location of the se- 
quence that corresponds to probes A and B is indicated by the black 
box within the ORF of lambda-Sg; lambdaEMBL3 sequen~s am re- 
prasented as hatched boxes, and Bluescript KS(+) sequences are re- 
presented as closed boxes at end of inserts, The T3 promoter of 
Bluescript KS(+) is shown for orientation purposes. Arrows: summary 
of sequencing runs in which the beginning of the arrows denotes the 
first readable nucleotid¢ after the sequencing primers and the length 
of the arrows describes the number of readable nueleotides obtained 
with each primer. The 0.8-kb markers correspond to representations 
of phage and total Bluescript inserts; the 0.2.kb markers correspond 
to amplified regions of Bluescript inserts and the sequencing arrows 
alisugd bequeath em. Nucleotid¢ numbering refers to human DNA 
s~quences in ~lueseript, where the A of the initiator ATG is nt 1. 
Plasmid pK-S31 is the expression plasmid obtained upon subeloning 
the Acel/BspHl frag"ment containing the ORF of pBS-S31.2 into 
pKNH. 
2.3, Subclon#zg of the fidl-length ORF #tto the eukaryotk' expression 
vector pKNH 
pKNH, a kind gift from Prof. S, Numa, Kyoto, Japan, contains two 
SV40 origin/promoter/enhancer sequences, one directing the expres- 
sion of the Neomycin resistance gone, the other directing the expres- 
sion of ORF's cloned into its unique Hindlll site (Fig, IB, for details 
see [15]). A fragment containing the ORF derived from tambtla.S31 
was excised from Bluescript DNA. isolated by 0.7% agarose gel el¢c- 
trophoresis, cleaned using Geneclean, rendered blunt-ended with 
Klenow fragment of DNA polymerase I, and subeloned into Hindlil- 
digested, blunt-ended and dephosphorylated pKNH vector. 
2.4. Tramfection of eukaryottc express/on vector pKNH with ptttatit,e 
serotoni~ receptor b~sert blto murhle Ltk- cells, and ident~cation 
and isola'tion of transformed cell clones 
Mouse Lt,~:-(~-HT) cells (a gift from Dr. Frank Ruddl¢, Dept. of 
Biology, Yal e University) were cultured, transf~ted and selected as 
described previously [16-18]. 
2.5. Drugs 
L(-)lsoproterenol (lso), L(-)epinephriae, serotonin CS-HT), do- 
paining, histamine and melatonin were from Sigma Chemical Com- 
pany (St. Loui.% MO). Forskolin was from Calbiochem (Salt Diego, 
CA), 
3. RESULTS AND DISCUSSION 
3.1. Cloning of a full.length ORF from a human genomic 
library 
In order to clone a novel scrotonin receptor we 
screened at low stringency ca. 1 × 106 recombinant 
lambdaEMBL3 phages from a human genomic D1NA 
library that had been amplified twice, using as probe a 
mixture of two 69-nt long oligonudcotidcs (probes A 
and B, see under oligonugleotides above). One of the 
plaque-purified positive clones, $8, contained a partial 
ORF that showed sequence homology to 5-HT re- 
ceptors, but by comparison, appeared to be a novel 
type. Fig. 1A presents the steps taken to characterize 
this insert. Clone $8 contained a partial ORF of 429 nt, 
located at the 3' end of a 2.5-kb XbaI/Sall fragment 
adjacent o lambda DNA. Both strands of this ORF 
were sequenced fully in Bluescript KS(+) as shown. The 
whole Xbal/Sall fragment was nick-translated and used 
to screen the same genomic library at high stringency. 
Four recombinant phages were plaque purified. Restric- 
tion mapping indicated that three were derived from the 
same cloning event as lambda-S8. The fourth, lambda- 
$31, descended from a second cloning event. A 4.4-kb 
PstI/PstI fragment was subcloned into Bluescript 
KS(+), to give pBS-S31.2, and sequenced as shown in 
Fig. 1A. Its nucleotide composition was identical to that 
of pBS-S8.1 except hat it contained a complete ORF 
of 1095 nt. The nueleotide sequence and predicted 
amino acid composition of the putative serotonin re- 
ceptor encoded in clone $31 are shown in Fig. 2. 
3.2. !dent~cation of clone S3J as a G protein-coupled 
serotonin receptor 
The deduced amino acid sequence of the longest open 
reading frame present in the recombinant DNA frag- 
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-347 AAAAAAA GTATCCTTT(3 
ASGAACAATG TAACGATSAG CTCAA~rTCC ACAGSAAA~ GAAAATTAAA ATTTATAAA~ AAq~TATAAA TATC~A TTgTCATGTT TTCCASGAAA AGTGT~ 
TCTCATTCAT TAACCAATAG CATAATATTT TCCAGSAACC TTCACTCAGA ASAAATGCTO TGGCCCTTCC CTTTAC~ AGAAAATGGA ACACAAGASA CCACATAGCT 
GAACAAAT~A TASCC~CCTT ACAA~TGAGA AACCT~O3AG GCTACATAGT ~TTCAGCCAA AC~AAAATAA CCAACAGCTT CTCCACAGTG TAGACTGAAA CAAGGGAAAC 
Met A~n I le Thr  Ash C~,S Thr Thr Slu Ale Set Mo~. Ale lie Ar~ Pro Lys Thr Ile Thr Glu LYslMet Leo Ile t~2s Met Thr L~u Val 
ATS ~ '~ ATC ACA ~ TOT Ace ACA ~AO GCC AGe ATS OCT ATA AGA CCC AAG ACe ATC ACT GAG AASIST ~- t~c AT~ e~C ;%T~ ~C~ t'~. ~Wa 
va~I- le T~r ~'hr 
~TC ATe ACe Ace 
I lo  C~ So[ Leo 
ATe TOT Tc~ era  
Sly Tyr Phe Luu 
SOS TAC "fTC L"~'C 
Tyr Tr~ Ale Ile 
TAC TOG GCC ATC 
-f-l-e-P~e Tie Set 
~ ,~.c ~T c Tcq 
Leu 
C~C 
~S 
Ale 
C, CC 
Thr Thr Leu Leo Ann Lmu Ale Val fie 
h~9 ~co q~rs e~c AA c TTG c~T ~ra A~C 
Va'l~hr ho~ Leo ,r.,e~ Va~ hla vax ~eu 
GTG ACG SAC CTC CTS STG SeA GTG CTC 
-fle Tyr '?lar Ile 
ATe TAC ACC AT~ 
95 
Cy=. CduIVal Trp Leu Set Val Asp Met" Tnr 
TOT ~AGIaT~ T~ ¢'TS get ~ SAC ATe ACe 
125 
Thr Asn Ale Ii~ Slu TTr Ale ArG Lye Arc 
ACC AAT GCT ATT SAA TAC SCC AGO AAS AGG 
Me~ Pro Pro Lau PheITrP Arg Set His Ar~ 
A~G CCC OCT CTG T~CITGG ASA AGC CAC C~C 
~SS 
'l~r Set q'~r Leu Sly Ala Phe Tyr Ile Pro 
TAC TCC ACG CTS GOT SCG TTT TAT ATC CCC 
55 
Gin 
CAG 
Mot 
ATS 
115 
215 
Set Leo Tyr Gln Lys 
AGC CI'T TAC CAO AAA ~45 
Thr Phe C'/s Val Set 
ACT TTC TOT ST~ TCT 
275 
Asp Leo Aflp His Pro 
SAT C?A ~AT CAC CCA 
"ilo LOs Set Trp Leu 
Ar~ GIy ~ Set Ar~ Hie Leo ~ ASh 
AG~ GGA TCA AGT eGG CAC TTA AGC AAC 
Asp Phe ~ Thr set  Anp Pro Thr 
SAC TTC TCC ACC TCA SAC CCT ACC ACA 
Sly GIu Ar~ Gln Sln Ile Set 8e~ Thr 
GGA GAb, COT CAG CAG ATC TCT AGC ACC 
Pro Phe Phe I-la Ly~ Slu Leo Zle Val lSlY 
CCA TTT TTC ATC AAA GAG ~G ATq' ~GI~T 
Trp Lau S ly  ,l'y= Va:t 
, ran  ere  ~'gT T ~ c~= 
365 
Met Ale IIeIGIy Thr Thr Gym byu L~u Hi~ 
ATG GC~ ATTICCC ACC ACC AAG AAS CTC CAC '7.~ • 65 
Val Meu Pro L~u Set I I~ l le lTYr  lira Val 
GTC,A, TG CCC CTG AGe ATC bTCITAC ATT GTC 
C~e Cy~ Thr Cy~ Set Ile Lau ~i~ Lea C~ V~l 
ff~C T~¢ ~%CC ~GC TCC ATC t'~ C CAC t'PC TG~ GTC 
135 
Tier Ale Lys Ar~|Ala Ala Leu Met Zle L~u 
ACe ~C AAS AGO IC<=C C, CG CTS ~:PG ATC C"T~ 
165 
Ar~ Leu Set Pro Pro Pro Set Gln cys Thr Ii~ 
CGC eTA AGe CCT CCC C~T AGT CAG TGC A~ ATe 
195 205 
Leu Thr beu II~ L~u II~--L~uITYr Tyr A~ %10 
TgS ACT q~O ATA CTS ATT CTCITAT TAC C~G ATT 225 22S 
Aro Ser Thr Asp Set Gin Asn Set Phe Ale 
AGA ASC ACA SAT AGC CAG AAT TCT TTT C~A AGT 2.%5 265 
GIQ Phe Slu Lys PhQ His Ala ~ Ile Ar~ II~ 
GAG TTT C, AA AAG TTC CAT ~CC TCC ATC A~G ATC 
Ar~ Slu Ar~ Lye Ale Ale Ar~II1e Lmu u~y L~u 
AGO GAA COS RAG GCA C~A CGCIA~C cPn c~m c '~ 
Ann Set Leu lie Ann Pro Leu Leo Tyr Thr 
AA~ Tcq~ CPO ATC AAC C~F O?G C~ T~'P ACe 
Thr 
ACe 
175 
cc~ co= ~c  TACI~'b 
A-p Ar~ 'Trp Ly- L~u 
SAT C~C 'I~O AAG CTT 
L_ 
Ilo A1a I~ulA~P Arg 
ATT ~CC eTc.|SAC AGO 
Val T r~Thr  Ilo Sot 
GTC ~G A~ ATe T(=C 
Gin Si~ A~p H i~[~ 
CAG CAC SAC CAT I~TT 
~Tr Itis Ale Ale Lys 
TAC CAC ¢~ ~CC AAG 
~'~o Lys L~u Thr Gln 
T~T AAA CTT ACA CAG 
Pro Pro Pho Asp ASh 
CCC CCC TTC SAC /..AT 
Ilo L~u GIM Ale Phe 
ATT C~ C~ C~A q~PC 
32 ~, • 
Leo ~r  ] le  q'Yr Thr Val S~r S,~r ~lu|gal--~?la A~p Ph~ L~u T~r 
CT~ AGe ATe TAC Ace GT~ TCC TCO GAAIGI'G C.-CC e.AC TT~ C~m ACG 
355 
Set P~elAsn GILl Ao~ Ph,, Ly~ L=u Ale Ph= Lye Ly~ L~u ~l= At0 
AS9 q~TgIAAT GAA ~AC ~'PT AAG CTG Gt'T ~]~T AAA AAG CTC ATT AGA 
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Cys Ar~ Glu Hie Thr " ' '  
T~C C~^ ~A~ CAT ACT TAO AC T~T~C TAA~C~CAC C~CT~r~CC ACACCCrCAT ~A=r~ATC~ C~Tm~C~o ~GC~CTTAT T~A~CTTaA 11~0 
ACATACTTGS TTCAGaAOAG TT~AA~rA ~T~TaOTCr ~ST~CC~'= TTT~T~ T~TGTTC TOT~'~TT ~C~T~ A~r~C~ cr~n~Tcr~ za~o 
cc~cr~a~c~ A~AT ACA~AA~T~C AAA~AAACA~ ~ATCA~ACAA AAACA~AN~ ~A~AA~ ~AA~AA~AA~ ATGAAA~AC~ AAA~ACC~ TA~C~GTTT~ 1~00 
Fig, 2, Nucleotid¢ sequence and deduced amino-acid sequence of  human DNA containing the ORF encoding the $31 reexptor. Sexluenees 
corresponding to the putative seven transmembrane regions are boxed. The two potential asparagine.linked glycosylation sites in the N-terminal 
extraccllular domain are indicated with double underline, String and thrconine residues located in consensus sequences for phosphorylation b)' 
cAMP-dependent protein klnases, protein kinases C or casein kinase II are indicated in bolded italics with single underline. The nucleolide sequence 
has been submitted to the EMBL Data Library (acacssion o. g l  1166), 
ment recognized by probes A/B in lambdaEMBL3 clone 
S31, was analyzed for its hydropathy profile and tested 
for similarity to G protein-coupled receptors, especially 
serotonin receptors. As indicated by both these analyses 
(Figs. 3 and 4), the deduced sequence had the landmarks 
of  a G protein-coupled receptor (for review, see [19]): 
(1) it exhibited seven stretches of hydrophobicity en- 
compassing ca. 20 amino acids, of which six stretches 
reached hydropathy indices of 2 and the last was less 
clearly circumscribed (Fig. 3); and (2) it showed exten- 
sive relatedness to other G protein-coupled receptors 
(shown for serotoniu receptors in Fig. 4 and Table II). 
In both Figs. 2 and 4, the most likely stretches of amino 
acids involved in spanning the plasma membrane are 
highlighted (as boxes in Fig. 2 and by asterisks in Fig. 
4). The ATG assigned as the start codon is the first 
ATG downstream of an in.frame stop codon (TGA in 
position - 15 to - 13) and conforms to the requirement 
of having a purine in position -3  suggested by Kozak 
[20]. The very short N-terminal, extracellular end of the 
predicted amino acid sequence contains two consensus 
asparagine-linked 81ycosylation sites (Asp-2 and Asp- 
5). The putative third intracellular domain is approxi- 
mately 90 amino acids long and contains one consensus 
cAMP-dependent protein kinase site (Set-218), five con- 
sensus protein kinase C sites ($erine residues in posi- 
tions 218, 223, 235, 262, and 283), and three consensus 
casein kinase II phosphorylation sites (Ser-248, Thr- 
254, and Ser-283) [21,22]. The intracellular carboxyl- 
0 f. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   looQa ~'1 ~ ~ ~ ~ ~ i l  ~ '  3"1~"""" ] 
"~ '  . . . . . . . . . . . . . . . . .  ~ 1  . . . .  ~ ' "  . . . . . . . . . . . . . . . . . .  
Fig. 3. Hydropathy plot for the protein encoded in clone S31 calcu- 
lated according to Kyte and Doolinle [25] with a movin8 window ,of 
nine amino acids. 
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Table I
Effects of various receptor ligands on adenylyl cyclase activity in L 
cells expressing the open reading frame encoded in clone $31 
Additions to the assay Adenylyl cyclase activity 
(pmol/min/mg protein) 
PGEh 10 #g/ml 30.6+0,3 
NaF 10 mM 25.0±1.6 
None 0.7±0.1 
Forskolin 100/tM 35.9 + 1.3 
+ 10 #M serotonin 23.5 ±0.6 
+ 10/aM isoproterenol 33.3 + _ 1.0 
+ 10/aM epinephrine 35.3_+ 1.1 
* 10 ,aM histamine 32.6_*0.9 
+ 10/aM dopamine 36.7+0.6 
+ 10/aM melatonin 33.3*--0.7 
Adenylyl cyclase activity was measured by determining the conversion 
of [CZ-'~ap]ATP to['~"P]cAMP in total cell homogenates. LS31/27.9 ~lls 
were grown to close to confluency, split 1:5 into 15 cm dishes and used 
48-60 h later. For this the medium was aspirated and the cells were 
washed twice with ice-cold BSS supplemented with 0.01% glucose, 
detached with the aid of a rubber policeman in the presence of BSS/ 
0.01% glucose, and collected by centrifugation. After pelleting, the 
cells were resuspended in 1.5 ml/dish of ice-cold 27% w/w sucrose, I 
mM EDTA, 2 mM MgCI: and 20 mM Na-HEPES, pH 7.5, and 
homogenized ina 7-ml Dounce homogenizer (8strokes with the tight 
pestle). The resulting homogenates were kept on ice for 15-30 rain 
prior to assay. Aliqaots of 10 ~1 (5/.tg protein) were then tested for 
adenylyl cyclase activities as described previously [8] in the presence 
of the indicated compounds. Incubations ~.ere in triplicate for 20 rain 
at 32°C. Rcsults are means ± SD (n=3). Similar results were obtained 
for each of the compounds on at least three occasions. 
terminal tail has the same short length as that of RDC4 
and the two cloned human 5-HTtD receptors (MA6A [7] 
and S12 [8]). A short intracellular tail seems to be a 
feature common to receptors coupled to inhibition of 
adenylyl cyclase. In this regard, the human 5-HT~a re- 
ceptoro which also inhibits adenylyl cyclase [23,24], has 
an intracellular tail that is only one amino acid longer 
(Fig. 4). 
Table 1I shows that homologies amoung the sero- 
tonin receptors so far cloned. The percent identity was 
calculated over the two long stretches of highest simi- 
larity among the G protein-coupled receptors, i.e. trans- 
membrane domains 1 through 5 and transmembrane 
domains 6 through 70 where only very few gaps had to 
be introduced to optimize the alignments (Fig. 4). As 
seen from Table 11, receptor $31 shows greater simi- 
Table 11 
Amino acid identity between homologous domains of cloned sero- 
tonin receptors 
RDC4 h5HTjD hSHTtD $31 hSHTIA rSHTic rSHT, 
(MA6A) {S12) 
droSHT 44.6 46.4 43.1 40.4 47.9 31.8 34.1 
RDC4 90.3 74.3 56.6 51.9 35.4 34.3 
h5HTtt~ (MA6A) 73,5 56.9 52.2 35.4 34.0 
hSHTto (S12) 59.2 53.0 34.3 34.3 
$31 49.8 36,0 38.2 
hSHTIA 34.3 34.3 
r5HT~c 72,7 
The table shows the amino-acid i entity between the cloned serotonin 
receptors in and between the transmembrane regions (amino acid -I 
from the beginning of the first TM segment through + 1 i after ending 
of TM5 and from -8 from the beginning ofTM6 through ÷15 after 
ending of TM7). The compared sequences are: droSHT, drosophila 
5.HT receptor [11]; RDC4, the canine receptor.like s quence RDC4, 
showing highest homology to 5-HT r~eptors [9]; hSHT~t~ (MA6A), 
human 5-HT m receptor [7]; h5HTjt~ (S12), human 5-HTjt~ receptor 
18]; $31, the present novel human serotonin receptor; hSHTzA, human 
5-HTI/~ receptor ('G-21' [2]); r5HTjo rat 5-HT~c r~.meptor [4]; rSHT:, 
rat 5-HT,. receptor [5,6]. 
larity to the two cloned human 5-HTtD receptors and 
RDC4 (59.2, 56.9, and 56.6% to 5-HTtD (S12), 5-HTtD 
(MA6A), and RDC4, respectively) than to any of the 
other receptors. On the other hand, the similarity of 
receptor $31 to any other receptor is lower than that 
between other functionally of pharmacologically related 
serotonin receptors (compare to 72.7% between rat 5- 
HTtc and rat 5-HT2, and 73.5% between the two cloned 
human 5-HT,t~ receptors (MA6A and S12)). 
3.3 Demonstration that clone $31 encodes a fiotctional 
serotonin receptor by expression in Ltk- cells 
The identity of the $31 protein was then established 
by transfection into Ltk- cells, which have been used by 
us as model systems to test for receptor function [16-- 
18]. A blunt-ended Aecl(-16)/BspHl(1140) fragment of 
pBS-S31.2, comprising 1156 nt of human genomic 
DNA containing the complete ORF, was subcloned 
into the expression vector pKNH (Fig. 1B) to give pK- 
$31o and transfected into Ltk- cells. Twenty-two Q418- 
resistant colonies were picked, expanded, and tested for 
adenylyl cyclase activity in the absence and presence of 
serotonin. Of these, 7 cell clones showed between 15 and 
<-.. 
Fig. 4. Primary amino acid sequence comparison between cloned serotonin rec,:ptors. Tile represented sequences are: droSHT, Drosophila 5-HT 
receptor [11 ]; RDC4, the canine receptor-like s quence RDC4, showing highest homology to 5-HT receptors [9]; hSHT-ID (MA6A), human 5-HTt D 
receptor 1"7]; hSHT-ID (S12), human 5-HTjt~ receptor [8]; $31, the present novel human serotonin receptor; hSHT-IA, human 5-HTjA receptor 
('G-21' [2]); rSHT-IC, rat 5-HT~c receptor [4]; rSHT-2, rat 5-HT, receptor 15.6]. Gaps introduced to optimize the alignments are repre.~ented with 
dashes (-). Tile boxes indicate amino acids that are identical in at least five of the eight compared receptors. The seven putative transmembrane 
domains of the human $31 receptor are indicated with stars above and below the ~equenees, and have been derived by a combination f hydropathy 
analysis [25] and comparison with the suggested transmembrane domains of the other G protein-coupled receptors. The amino-acid sequence shown 
for the human 5-HT~A receptor is that determined by us I8]. 
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29% inhibition of adenylyl cyclase in response to sero- 
tonin. Several clonal cell lines were derived by limiting 
dilution from these initial cell clones. The inhibitory 
response to serotonin persisted. One cell line, LS31/ 
27.9, was expanded and used for the experiments hown 
in Table I. As seen from the table, serotonin consistently 
gave a 30-35% inhibition of forskolin-stimulated ade- 
nylyl cyclase activity in homogenates from the clonal 
cell line LS31/27.9, expressing the putative receptor. No 
significant inhibition of forskolin-stimulated adenylyl 
cyclase activity was observed with any of the other 
drugs tested (isoproterenol, epinephrine, histamine, do- 
pamine, and melatonin). Also, parental Ltk- cells were 
unresponsive to serotonin (not shown). 
Taken together, these results strongly suggest that 
clone $31 encodes a functional G protein-coupled sero- 
tonin-receptor mediating inhibition of adenylyl cyclase. 
The relatively low homology of this novel serotonin- 
receptor to other cloned serotonin-receptors may indi. 
.-.ate that it will also display a novel pharmacological 
profile. 
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